MarketsandMarkets OncoGene

WHAT TO EXPECT

Use of digital biomarkers for drug development, Multi-Omics prospects (Epigenomics, Proteomics, Transcriptomics, Pharmaco genomics)
Inception of technologies for Precision Medicine – Impact of big data, Artificial intelligence, and Machine Learning, Insilico trials for Precision medicine
Cost benefit issues, Regulatory, Ethical and Social challenges in Precision Medicine
Updates in development of ADC’s and Bispecific Ab’s
Immune Checkpoint Inhibitors and Combinations
CAR-T Cell therapy, TCR Based-Cell Therapy
Tumor microenvironment and Oncolytic Viruses
Gene Expression and Molecular Mechanism in Immune Signaling, Flow Cytometry in Immune Phenotyping, Polygenic Risk Scores for Immuno Metabolic Markers
Electrospray Mass Spectrometry based Biomarkers, Development of Multidimensional Liquid Chromatography, Spatial Profiling in Tumor Proteomics
Advances in Genome Wide Variant Data and Application of Omics in Protein – Protein interaction

Witness live action how precision medicine is revolutionizing the future of healthcare
Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing precision medicine
Discover the different avenues in patient centric care
Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
Explore the latest platforms and technologies on the market for development
Discuss the best tool for your research in immune-oncology
Comprehend the current and future research avenues in drug discovery using Genomics and Proteomics
Discuss the emerging technologies and opportunities with cutting edge strategies
Opportunity for one-on-one networking with the delegates and extend professional competency

Industry: Pharma/Therapeutic Companies/Start Up’s
CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Geneticists, Bioinformatician, Protein Scientist, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data Science
Academics: Universities, Research Institutes, Hospitals
Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
Departments: Genomics, Proteomics, Oncology, Molecular Biology, Genetics Bioinformatics, Computational Biology, Protein science, Pharmacogenomics, Biotechnology, Data science

CONFERENCE AGENDA

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening remarks from the Chairman

08:55 - 09:00

New Antibody Formats & Cellular Therapy
Keynote:	09:00 - 09:30
Solution Provider Presentation	09:30 - 10:00
Precision Medicine in IO-Case study	10:00 - 10:30
Morning Refreshments and Poster Presentations \| One-to-One Networking Meetings	10:30 - 11:15
T-cell receptor signaling in Cancer Immunotherapy	11:15 - 11:45
Adoptive Cellular Therapy	11:45 - 12:15
Targeting cancer with ADC’s-Case study	12:15 - 12:45
Development of bispecific antibodies for cancer therapy	12:45 - 13:15
Lunch and Poster Presentations \| One-to-One Networking Meetings	13:15 - 14:15
Challenges in the nonclinical development of mAb-based cancer immunotherapy	14:15 - 14:45
Dendritic cell therapy in IO	14:45 - 15:15
Solution Provider Presentation	15:15 - 15:45
Afternoon Refreshments and Poster Presentations \| One-to-One Networking Meetings	15:45 - 16:30
Engineering CAR T cells for enhanced efficacy and specificity	16:30 - 17:00
Solution Provider Presentation	17:00 - 17:30
Choosing IO in multiple myeloma-Case Study	17:30 - 18:00
Closing remarks from the Chairman	18:00 - 18:00

Quantum Leap in Global approach to Biomedicine
Systemic Implementation of Functional Genomics in Biomedicine	09:00 - 09:30
Interaction and Organellar Proteomics for Biomedicine	09:30 - 10:00
Solution Providers Presentation	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meeting	10:30 - 00:00
Genomics and Proteomics in System Biology Approach
Protein – DNA Interaction – Significant Role in Molecular and Cellular Mechanism	11:20 - 11:50
Applied and Translational Genomics in Systems Biology	11:50 - 12:20
Solution Providers Presentation	12:20 - 12:50
Lunch and Poster Presentation \| One-to-One Networking	12:50 - 13:50
Future Expansion of Epigenomics in Systems Biology Research	14:50 - 14:20
Integration of Genomics and Proteomics in Immune Signalling
Proteo-Genomics and Immunopeptides	14:20 - 14:50
Advancement in Flow cytometry – Mainstay in Immune Phenotyping	14:50 - 15:20
Panel discussion –De Novo Analysis of Genomic/Transcriptomic datasets – Analysis of Variant Peptide	15:20 - 16:00
Evening Refreshments and Poster Presentation \| One-to-One Networking	16:00 - 16:50
Investigating Gene Expression and Molecular Mechanism in Activation and Regulation of Immune Signaling	16:50 - 17:20
Quantum Leap in Global approach to Biomedicine
Solution Providers Presentation	17:20 - 17:50
Polygenic Risk Scores for Immuno-Metabolic Markers	17:50 - 18:20
Closing remarks by the Chairperson	18:20 - 18:20

Overview of precision medicine
‘Customizing Specific treatment to specific genomic characteristics of individuals’ – Overview of Precision Medicine	09:00 - 09:30
Quantum leap in Genomic Biology and Genomic Medicine	09:30 - 10:00
Solution Providers Presentation	10:00 - 00:00
Morning Refreshments and Poster Presentation \| One-to-One Networking Meeting	10:30 - 11:20
Inception of technologies in precision medicine
Impact of Big data in Precision Medicine	11:20 - 11:50
New realm of precision medicine- Artificial Intelligence and Machine Learning	11:50 - 12:20
Solution Providers Presentation	12:20 - 12:50
Lunch and Poster Presentation \| One-to-One Networking	12:50 - 13:50
In Silico Trials for Precision Medicine – Role of computational biology	13:50 - 14:20
Precision approaches to Tumor Oncology
Use of tumour-associated antigen targeting Humabodies to deliver CD137 agonism to the tumour microenvironment Andrew Pierce, Vice President, Translational Biology, Crescendo Biologics	14:20 - 14:50
Phage-guided delivery of nucleic acid therapeutics in oncology and other human diseases Amin Hajitou, Professor, Chair of Targeted Therapies, Imperial College of London	14:50 - 15:20
Solution Providers Presentation	15:20 - 15:50
Evening Refreshments and Poster Presentation \| One-to-One Networking	15:50 - 16:50
Future Purview of Precision Medicine
Use of AI and machine learning algorithms to provide rapid and accurate antibiotic susceptibility testing, tackling antimicrobial resistance one test at a time Stuart Hannah, CEO, Microplate Dx Ltd	16:50 - 17:20
Solution Providers Presentation	17:20 - 17:50
State of the art – Digital health in Precision Medicine	17:50 - 18:20
Closing remarks by the Chairperson	18:20 - 18:20

Registration

08:15 - 08:50

Welcome note from MarketsandMarkets

08:50 - 08:55

Opening remarks from the Chairman

08:55 - 09:00

New Immune Checkpoints, Biomarker and Tumour Microenvironment
Keynote:	09:00 - 09:30
Solution Provider Presentation	09:30 - 10:00
Role of Tumour Micro-Enviroment in Oncolytic Viral Therapy	10:00 - 10:30
Morning Refreshments and Poster Presentations \| One-to-One Networking Meetings	10:30 - 11:15
Solution Provider Presentation	11:15 - 11:45
New IO Combination therapies and Biomarkers	11:45 - 12:15
Next-generation checkpoints beyond PD-1 and CTLA-4	12:15 - 12:45
Lunch and Poster Presentations \| One-to-One Networking Meetings	13:15 - 14:15
Combining oncolytic viruses with immune checkpoint inhibitors	14:15 - 14:45
Solution Provider Presentation	14:45 - 15:15
Immunomodulation in IO	15:15 - 15:45
Closing remarks from the Chairman	15:45 - 15:45

Comprehensive Analysis of Quantitative Genomics
Next Generation Sequencing (NGS)- RNA sequencing/Microarray in Predisposition of Biomarkers in Rare diseases	09:00 - 09:30
Single Cell Sequencing using Circulating Tumor Cells in Disease Diagnosis	09:30 - 10:00
Morning Refreshments and Poster Presentation \| One-to-One Networking	10:00 - 00:00
Application of Shotgun Proteomics in Diagnostics
Electrospray Mass Spectrometry based Biomarkers using Cell Proteomics	10:50 - 11:20
Solution Providers Presentation	11:20 - 11:50
Development of Multidimensional Liquid Chromatography – Application in Clinical Proteomics	11:50 - 12:20
Lunch and Poster Presentation \| One-to-One Networking	12:20 - 13:20
Spatial Profiling – Advances and Digitization in Tumor Proteomics	13:20 - 13:50
Solution Providers Presentation	13:50 - 14:20
Afternoon Refreshments and Poster Presentation \| One-to-One Networking	14:20 - 15:10
Changing Research in Omics Data
Advances in Genome Wide Variant Data	15:10 - 15:40
Application of Omics in Protein – Protein Interaction	15:40 - 16:10
Artificial Intelligence / Machine learning in Genomics and Proteomic Data Strategy	16:10 - 16:40
Closing remarks by the chairperson	16:40 - 16:40

Precision Medicine in Disease Prediction and Treatment
Achieving precision medicine in chronic diseases: from patientfocused drug discovery to personalized prediction, prevention, and treatment Dr Steve Gardner, CEO and Co-founder, PrecisionLife, UK	09:00 - 09:30
CAR T-cell immunotherapy of solid tumours: Parallel learning from the clinic and lab John Maher, Scientific Founder and Chief Scientific Officer, Leucid Bio	09:30 - 10:00
Morning Refreshments and Poster Presentation \| One-to-One Networking	10:00 - 10:50
Precision Medicine and Pharmacogenomics
Using digital biomarkers for a precision medicine approach to neuroscience drug development Jennifer Barnett , CEO, Monument Therapeutics	10:50 - 11:20
Solution Providers Presentation	11:20 - 11:50
Use of spatial transcriptomics to identify differentially expressed biological pathways in SEGA brain tumours from patients with Tuberous sclerosis complex Hywel Williams, Senior Lecturer in Bioinformatics, School of Medicine, Division of Cancer and Genetics, Cardiff University	11:50 - 12:20
Lunch and Poster Presentation \| One-to-One Networking	12:20 - 13:20
Panel discussion - No one marker for one cancer – evolution of markers in common cancers	13:20 - 13:50
Solution Providers Presentation	13:50 - 14:20
Afternoon Refreshments and Poster Presentation \| One-to-One Networking	14:20 - 15:10
Comprehensive genomic profiling
Droplet Microfluidics for personalized cancer therapy Christoph A. Merten, , École Polytechnique Fédérale de Lausanne (EPFL)	15:10 - 15:40
Large scale implementation of population wide polygenic risk scores Manuel Corpas, Scientific Director, Cambridge Precision Medicine	15:40 - 16:10
RNA activation in genetic and acquired diseases Nagy Habib, Founder and Head of R&D, MiNA Therapeutics	16:10 - 16:40
Closing remarks by the Chairperson	16:40 - 16:40